Search clinical trials for: 68Ga-PSMA-11

Total 1601 results

University of Texas Southwestern Medical Center
Telix International Pty Ltd; Once Upon a Time Foundation

Recruiting

PSMA PET Response Guided SabR in High Risk Pca

Prostate Adenocarcinoma

United States
Mayo Clinic

Active, not recruiting

PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer

Prostate Cancer

United States
Thomas Hope

Completed

Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients

Prostate Cancer

United States
National Cancer Institute (NCI)

Enrolling by invitation

18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer

Prostate Cancer | Metastatic Prostate Cancer | Cancer Of Prostate | Prostate Neoplasms | Prostatic Cancer

United States
Michael Graham PhD, MD

Active, not recruiting

Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer

Prostatic Neoplasms | Prostatic Neoplasms, Castration-Resistant

United States
Michael Graham PhD, MD
University of Iowa; Holden Comprehensive Cancer Center

Active, not recruiting

68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer

Prostate Cancer | Prostatic Neoplasms, Castration-Resistant | Prostatic Neoplasm | Prostatic Cancer Recurrent | Prostatic Cancer Metastatic

United States
Astellas Pharma Inc

Completed

A Study to Assess the Safety, Pharmacological Effect and Plasma Concentration of ASP7991 After Single Oral Administration to Healthy Volunteers

Healthy | Pharmacokinetics of ASP7991

Japan
Peking Union Medical College Hospital

Recruiting

68Ga-pentixather and 68Ga-pentixafor PET/CT in Multiple Myeloma

Multiple Myeloma

China
Michael Graham PhD, MD
University of Iowa; Holden Comprehensive Cancer Center

Completed

68Ga PSMA in Preprostatectomy Patients

Prostate Cancer | Prostatic Neoplasms, Castration-Resistant | Prostatic Neoplasm | Prostatic Neoplasm of Uncertain Behavior

United States
Norwegian University of Science and Technology
University Hospital of North Norway; Haukeland University Hospital; St. Olavs...

Recruiting

Combined PSMA PET/MRI for Detection of Lymph Node Metastases in High-risk Prostate Cancer Patients

Prostatic Neoplasms | Neoplasm Metastasis

Norway
Andrei Iagaru
General Electric

Completed

68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU Therapy

Prostate Cancer

United States
Peking Union Medical College Hospital

Recruiting

Application of 68Ga-Pentixafor PET/CT for Thymoma

Thymoma

China
PentixaPharm GmbH

Terminated

[68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients

CNS Lymphoma

Denmark, France
Peking University Cancer Hospital & Institute
Peking University Health Science Center

Recruiting

68Ga-ICAM-1pep PET/CT in Cancer Patients

Cancer

China
Xiangya Hospital of Central South University

Completed

Clinical Translation of a Novel FAPI Dimer [68Ga]Ga-LNC1013

Gastrointestinal Cancer

China
Norwegian University of Science and Technology
University Hospital of North Norway; Haukeland University Hospital; St. Olavs...

Completed

PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment

Prostatic Neoplasms

Norway
University of Alberta

Active, not recruiting

18F-PSMA-1007 PET/CT Imaging in Patients With Biochemically Recurrent or High-risk Prostate Cancer

Prostate Cancer

Canada
Yusuf Menda
National Cancer Institute (NCI); National Institutes of Health (NIH); Holden...

Active, not recruiting

Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors

Neuroendocrine Tumors

United States
Hexin (Suzhou) Pharmaceutical Technology Co., Ltd
Wuhan Union Hospital, China

Completed

A Clinical Study of 68Ga-HX01 Injection for PET Imaging

Healthy | Malignancy

China
Sir Mortimer B. Davis - Jewish General Hospital

Terminated

Two TraCer PositROn EmiSSion Tomography ComBination for Efficacy EstimatiOn of Prostate Specific Membrane Antigen Radioligand Therapy in Patients With Metastatic Prostate Cancer (CROSSBOW)

Prostatic Neoplasms | Prostate Cancer | Metastatic Prostate Cancer | Prostate Adenocarcinoma | Metastatic Prostatic Adenocarcinoma | Metastatic Prostate Carcinoma in the Soft Tissue

Canada
Peter MacCallum Cancer Centre, Australia
Endocyte; Movember Foundation; Medical Research Future Fund; E.J. Whitten Foundation...

Active, not recruiting

Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy (LuTectomy)

Prostatic Neoplasms

Australia
Insel Gruppe AG, University Hospital Bern

Completed

Diagnostic Accuracy and Performance of 18F-PSMA-1007

Prostate Cancer

Switzerland
First Affiliated Hospital of Fujian Medical University

Completed

A Head-to-head Comparison of [68Ga]Ga-FAPI and [68Ga]Ga-TATE PET/CT in Patients With Nasopharyngeal Carcinoma: a Single-center, Prospective Study

Tumor Positron-Emission Tomography

China
Medical University of Vienna

Recruiting

PSMA-RLT in Biochemically Recurrent PCa

Prostate Cancer Recurrent

Austria
University of Wisconsin, Madison

Terminated

PSMA PET and MRI in Gynecological Cancers

Gynecologic Cancer

United States
Glenn Bauman
United States Department of Defense; Western University, Canada; Centre for Probe...

Recruiting

Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy (IGPC-5)

Prostate Cancer | Prostate Adenocarcinoma | Prostate Neoplasm

Canada
Ipsen

Terminated

Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast Cancer

Breast Cancer

Austria
Peking Union Medical College Hospital

Recruiting

68Ga-FAPI PET/MR for Atherosclerosis

Atherosclerosis

China
Peking Union Medical College Hospital

Recruiting

Characterizing IgG4-RD With 68Ga-FAPI PET/CT

IgG4-related Disease

China
Peking Union Medical College Hospital

Unknown

Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic Disorders

Lymphatic Disorders

China
The First Affiliated Hospital of Xiamen University

Recruiting

Characterizing Myositis With 68Ga-FAPI PET/CT

Myositis | Idiopathic Inflammatory Myopathies

China
Peking Union Medical College Hospital

Recruiting

FAPI-PET/CT in Psoriatic Arthritis

Psoriatic Arthritis

China
Peking Union Medical College Hospital

Recruiting

Characterizing Rheumatoid Arthritis With 68Ga-FAPI PET/CT

Arthritis

China
Medical University Innsbruck
Novartis

Completed

68Ga-DOTA-MGS5 PET/CT in Patients With Advanced Neuroendocrine Tumours

Neuroendocrine Tumors

Austria
Jonsson Comprehensive Cancer Center

Completed

Investigation of 68Ga-DOTATATE, as a PET Imaging Agent in Neuroendocrine Tumor Patients

Neuroendocrine Carcinoma

United States
Peking Union Medical College Hospital

Unknown

Characterizing Inflammatory Bowel Disease With 68Ga-FAPI PET/CT

Inflammatory Bowel Disease

China
Peking Union Medical College Hospital

Unknown

Impact of Peptides and Chelators on Somatostatin Receptor Antagonists

Neuroendocrine Tumors

China
GlaxoSmithKline
Shionogi

Completed

GSK1349572 Drug Interaction Study With Etravirine

Healthy Subjects

United States
Peking Union Medical College Hospital

Recruiting

Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors

Neuroendocrine Tumors

China
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma

Renal Cell Carcinoma

China
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion

Clear Cell Renal Cell Carcinoma

China
Australian and New Zealand Urogenital and Prostate...
Astellas Pharma Inc; Endocyte; Prostate Cancer Research Alliance; National Health...

Active, not recruiting

Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer (ENZA-p)

Metastatic Castration-Resistant Prostate Cancer

Australia
Sir Mortimer B. Davis - Jewish General Hospital

Terminated

SUV on PSMA PET/CT in Non-Prostate Tumors

Cancer

Canada
Peking Union Medical College Hospital

Unknown

Characterizing SAPHO With 68Ga-FAPI PET/CT

SAPHO Syndrome

China
Turku University Hospital

Recruiting

99mTc-MIP-1404 SPECT/CT in Primary Staging of Prostate Cancer

Prostate Cancer

Finland
Peter MacCallum Cancer Centre, Australia

Recruiting

ProsTIC Registry of Men Treated With PSMA Theranostics

Prostate Cancer | Metastatic Castration-resistant Prostate Cancer

Australia
Heinrich Elinzano, MD
University of Texas; Rhode Island Hospital; Progenics Pharmaceuticals, Inc.

Completed

BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)

Glioblastoma Multiforme | Gliosarcoma | GBM

United States
Xinhua Hospital, Shanghai Jiao Tong University...

Unknown

Clinical Trial of Ac225-PSMA Radioligand Therapy of Metastatic Castration-resistant Prostate Cancer

Metastatic Castration-resistant Prostate Cancer
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses

Clear Cell Renal Cell Carcinoma

China
Peking Union Medical College Hospital

Recruiting

68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients

Lung Neoplasms

China

Search clinical trials for: 68Ga-PSMA-11

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations